Poll Finds Most Are Ignorant of Gaucher

Disease is little known among both Jews and doctors

By Elisha Sauers

Published August 25, 2006, issue of August 25, 2006.
  • Print
  • Share Share

In a recent telephone survey, researchers presented the following set of symptoms to hundreds of hematologists and oncologists from around the world: A 42-year-old man has complaints of chronic fatigue and bone pain, while suffering from a low blood-platelet count and an enlarged liver and spleen.

Had the patient been real and not hypothetical, he would have been misdiagnosed by four doctors out of five. The correct answer: Gaucher disease.

The poll, conducted by the biotech company Genzyme, found that most of the doctors surveyed would not even have asked for a Gaucher test.

Michael Schneider, associate director of marketing for Genzyme, found the results troubling. If doctors don’t test for Gaucher, he said, treatment will focus only on symptoms and not on the root cause of a Gaucher sufferer’s ills.

“We became alarmed by how low the awareness was of the disease,” he said. “I mean, we’ve been trying to educate people for 14 years on Gaucher disease. In fact, there are treatment centers that specifically know how to assess people on the disease. There is a very simple blood test they can do to positively identify patients to see if they are lacking a specific enzyme, but the fact is, if the doctors don’t consider Gaucher as a possibility they won’t get that test.”

Gaucher, a lipid-storage disorder that causes abdominal distention, bone deterioration and anemia, is the most common of all Jewish genetic diseases. According to the National Gaucher Foundation, one out of every 450 Ashkenazic Jews has Gaucher, and one out of every 15 is a carrier. If two carriers have children, one in four of their offspring will likely have the disease, Schneider said.

The general population is so unaware of Gaucher, said Walt Harris, Genzyme’s senior market-research manager, that as many as 8,000 people in the United States may have the disease and not know it.

“With Gaucher, you get death of bone,” Schneider said. “It is so extremely painful that, eventually, some of them have to be hospitalized and put on narcotics, and unfortunately sometimes that’s how people are finding out they have Gaucher — when they end up with this excruciating bone crisis.”

Schneider said that to overcome the lack of Gaucher awareness in the medical community, individuals should proactively seek testing if they know of anyone in their family who has had it.

A second survey conducted by Genzyme showed that lack of knowledge about the disease is just as prevalent among the Ashkenazic Jewish population, the community it most commonly affects, as it is among the population at large.

The survey reached a cross section of Jewish households among three heavily Jewish areas: New York, southern Florida and Los Angeles.

Kate James, one of the researchers on the project, said that only 6% of those surveyed were aware of Gaucher, with Jews in southern Florida being the least knowledgeable about the disease.

Of the Jewish households polled, 57% were familiar with Tay-Sachs disease and its symptoms, even though Gaucher is twice as common.

Rhonda Buyers, the National Gaucher Foundation’s executive director, finds these statistics particularly disconcerting.

“Tay-Sachs is fatal, and I think that causes people to sit up and listen,” she said. “But what people need to know is that Gaucher is serious, and it can be very painful and debilitating. We just have to get out there and keep educating.”






Find us on Facebook!
  • "'What’s this, mommy?' she asked, while pulling at the purple sleeve to unwrap this mysterious little gift mom keeps hidden in the inside pocket of her bag. Oh boy, how do I answer?"
  • "I fear that we are witnessing the end of politics in the Israeli-Palestinian conflict. I see no possibility for resolution right now. I look into the future and see only a void." What do you think?
  • Not a gazillionaire? Take the "poor door."
  • "We will do what we must to protect our people. We have that right. We are not less deserving of life and quiet than anyone else. No more apologies."
  • "Woody Allen should have quit while he was ahead." Ezra Glinter's review of "Magic in the Moonlight": http://jd.fo/f4Q1Q
  • Jon Stewart responds to his critics: “Look, obviously there are many strong opinions on this. But just merely mentioning Israel or questioning in any way the effectiveness or humanity of Israel’s policies is not the same thing as being pro-Hamas.”
  • "My bat mitzvah party took place in our living room. There were only a few Jewish kids there, and only one from my Sunday school class. She sat in the corner, wearing the right clothes, asking her mom when they could go." The latest in our Promised Lands series — what state should we visit next?
  • Former Israeli National Security Advisor Yaakov Amidror: “A cease-fire will mean that anytime Hamas wants to fight it can. Occupation of Gaza will bring longer-term quiet, but the price will be very high.” What do you think?
  • Should couples sign a pre-pregnancy contract, outlining how caring for the infant will be equally divided between the two parties involved? Just think of it as a ketubah for expectant parents:
  • Many #Israelis can't make it to bomb shelters in time. One of them is Amos Oz.
  • According to Israeli professor Mordechai Kedar, “the only thing that can deter terrorists, like those who kidnapped the children and killed them, is the knowledge that their sister or their mother will be raped."
  • Why does ultra-Orthodox group Agudath Israel of America receive its largest donation from the majority owners of Walmart? Find out here: http://jd.fo/q4XfI
  • Woody Allen on the situation in #Gaza: It's “a terrible, tragic thing. Innocent lives are lost left and right, and it’s a horrible situation that eventually has to right itself.”
  • "Mark your calendars: It was on Sunday, July 20, that the momentum turned against Israel." J.J. Goldberg's latest analysis on Israel's ground operation in Gaza:
  • What do you think?
  • from-cache

Would you like to receive updates about new stories?




















We will not share your e-mail address or other personal information.

Already subscribed? Manage your subscription.